There was some indication of splenomegaly and disorganization of lymphoid follicles in the spleen after LCL161 treatment however this is consistent with the ability of SMs to activate non-canonical NF-κB (Supplementary Fig. 4G). This evidence concerns the gene NFKB1 and Splenomegaly.